Area of research
Public Health, Environmental and Occupational Health · Pharmacology
Research interest
Research interests include Malaria Research and Control, Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, and Mosquito-borne diseases and control.
Artemether-Lumefantrine Treatment Selects <i>Plasmodium falciparum</i> Multidrug Resistance 1 (<i>pfmdr1</i>) Increased Copy Number Among African Malaria Infections
Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions
Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy
Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
Alternatively spliced transcripts and novel pseudogenes of the Plasmodium falciparum resistance-associated locus pfcrt detected in East African malaria patients
Temporal trends of molecular markers associated with artemether-lumefantrine tolerance/resistance in Bagamoyo district, Tanzania
Frequency of the Functionally Relevant Aryl Hydrocarbon Receptor Repressor (AhRR) Pro185Ala SNP in Papua New Guinea
Plasmodium falciparum Drug Resistance Phenotype as Assessed by Patient Antimalarial Drug Levels and Its Association With pfmdr1 Polymorphisms
<i>PXR</i> Variants and Artemisinin Use in Vietnamese Subjects: Frequency Distribution and Impact on the Interindividual Variability of CYP3A Induction by Artemisinin